NYSE: NVS - Novartis

Yield per half year: -11.03%
Sector: Healthcare

Reporting Novartis

Reports

IFRS
Reporting Annual
2016 2017 2018 2021 2022 2023
Финансовый отчет link link link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд $
198.33 181.3 151.63 172.78 174.69 215.02 196.2 203.49 190.91 210.48
Выручка, млрд $
50.39 49.44 50.14 53.17 48.68 49.9 52.88 51.83 46.66 46.66
Чистая прибыль, млрд $
17.78 6.71 7.7 12.61 11.73 8.07 24.02 6.96 14.85 14.85
EV, млрд $
215.56 197.98 170.57 188.9 190.44 239.57 199.11 220.09 219.54 219.54
EBIT, млрд $
8.79 15.04 15.9 14.79 9.09 10.15 26.95 9.68 10.19 10.19
EBITDA, млрд $
25.02 14.57 15.85 21.68 15.62 17.21 33.06 16.39 18.47 18.47
Баланс стоимость, млрд $
80.38 81.15 77.64 0.163 0.163 -10.21 3.88 59.34 46.67 46.67
FCF, млрд $
8.39 8.6 9.88 10.92 11.37 11.07 12.1 11.57 11.71 11.71
Операционный денежный поток, млрд $
11.9 12.62 14.27 13.63 13.63 13.65 15.07 14.24 14.46 14.46
Операционная прибыль, млрд $
8.98 8.27 8.63 8.17 9.09 10.15 11.69 9.2 9.77 9.77
Операционные расходы, млрд $
24.01 23.65 24.33 25.17 25.17 24.63 25.32 27.15 24.42 24.42
CAPEX, млрд $
3.51 2.88 2.75 3.36 2.26 2.59 2.97 2.67 2.75 2.75


Balance sheet

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд $
4.67 7.01 9.49 15.96 11.45 11.29 28.11 7.52 13.39 13.39
Short Term Investments $
0.773 0.77 0.625 2.69 0.334 1.91 15.92 11.41 0.569 0.569
Long term investments $
9.44 16.58 16.5 17.61 10.7 11.16 11.7 2.27 1.61 1.83
Total Receivables $
8.18 10.2 11.1 11.02 8.56 8.46 8.28 8.33 9.38 9.38
Total Current Assets $
22.85 24.93 28.21 35.56 29.5 29.67 45.72 36.91 30.48 30.48
Чистые активы, млрд $
77.05 74.83 74.17 55.47 55.47 56.6 67.66 12.2 52.06 12.2
Активы, млрд $
131.56 130.12 133.08 145.56 118.37 132.06 131.8 117.45 99.95 99.95
Short Term Debt $
5.6 5.91 5.2 9.62 7.28 10.07 6.57 6.18 6.31 6.31
Long Term Debt $
16.33 17.9 23.22 22.47 22.06 27.98 24.52 21.78 18.44 18.44
Задолженность, млрд $
54.43 55.23 58.85 66.87 62.82 75.39 63.97 58.03 53.2 53.2
Чистый долг, млрд $
17.23 16.68 19.57 15.75 15.75 24.56 2.91 20.45 12.96 12.96
Долг, млрд $
21.9 23.69 28.43 32.09 27.2 35.85 31.03 27.96 24.75 24.75
Interest income $
0.63 0.44 0.418 0.005 0.036 0.091 14.63 0.379 0.627
Расходы на обслуживание долга $
0.655 0.707 0.777 0.957 0.85 0.869 0.811 0.837 0.855 0.855
Чист. проц. доходы, млрд $
-0.684 0.418 0.005 0.036 0.091 14.63 0.379 0.627 0.627
Goodwill $
29.31 31.17 30.98 31.75 35.29 26.52 30 29.6 29.3 23.34
Амортизация, млрд $
5.58 0.0000 0.0001 6.89 6.53 7.06 6.11 6.71 8.28 8.28
Себестоимость, млрд $
17.4 17.18 18.41 14.43 14.43 15.12 15.87 15.49 12.47 12.47
Товарно материальные запасы $
6.23 6.26 6.87 6.96 5.98 7.24 6.67 7.18 5.91 5.91


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS 7.29 2.8 3.25 5.38 5.06 3.52 10.63 3.17 7.1 7.1
Цена акции ао 75.54 63.95 73.71 75.33 94.69 94.43 87.05 100.97 116.22 116.22
Число акций ао, млн 2438 2400 2371 2344 2319 2296 2260 2197 2092 2092
FCF/акцию 3.44 3.58 4.16 4.66 4.9 4.82 5.35 5.26 5.6 5.6


Efficiency

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
ROE, % 24.06 8.84 10.34 16.51 17.5 14.41 38.66 11.72 31.82 31.82 4.39
ROA, % 13.84 5.13 5.85 9.05 8.89 6.45 18.21 5.92 14.86 14.86 7.82
ROIC, % 19.28 7.37 8.23 12.39 12.51 9.73 25.58 16.28 30.95 27.51 17.25
ROS, % 17.27 19.5 27.82 29.53 21.54 50.97 13.42 31.83 31.83 31.83 11.86
ROCE, % 11.4 20.08 21.42 12.75 10.08 10.25 26.53 16.3 21.8 21.8 60.89
Рентаб EBITDA, % 49.65 29.49 31.62 40.79 32.08 34.49 22.78 31.62 39.58 39.58 19.98
Чистая рентаб, % 17.8 16.7 17.2 15.4 18.7 20.3 22.1 13.42 31.83 31.83 13.58
Operation Margin, % 16.72 17.21 15.37 18.67 20.35 22.11 17.75 20.94 20.94 20.94 15.10
Чистая процентная маржа, % 15.6 19.04 35.29 13.58 15.36 23.72 24.1 16.18 45.43 45.63 16.02
Доходность FCF, % 6.02 4.23 4.74 6.51 6.1 5.93 5.86 6.46 6.66 6.13


Coefficients

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
P/E
25.1 25.6 29.9 15 31.2 30.6 20.2 28.7 13.91 13.91 60.40
P/BV
2.7 2.3 2.7 2.5 4.1 3.9 3.4 3.36 4.42 4.42 8.80
P/S
4.1 3.5 4 3.8 4 4.4 3.8 3.85 4.43 4.43 4.56
P/FCF
14.11 14.68 14.07 17.42 18.49 15.99 15.01 18.19 17.98 17.98 14.73
E/P
0.0391 0.0436 0.0705 0.0373 0.0428 0.1282 0.0401 0.0778 0.0706 0.0706 0.18
EV/EBITDA
8.62 13.58 10.76 8.71 12.2 14.06 5.88 13.43 11.89 11.89 23.26
EV/Ebit
21.54 21.54
EV/S
3.81 3.91 3.72 4.28 4.32 3.87 4.25 4.71 4.71 4.71 4.75
EV/FCF
21.91 19.86 18.12 18.31 19.46 16.9 19.03 18.76 18.76 18.76 19.88
Debt/EBITDA
1.62 1.79 1.48 1.74 2.08 0.9383 1.71 1.34 1.34 1.34 3.50
Netdebt/Ebitda
1.2 1.3 0.91 1.09 1.6 0.53 1.25 0.7014 0.7014 0.7014 2.80
Debt/Ratio
0.42 0.44 0.46 0.53 0.57 0.49 0.2381 0.2476 0.2476 0.2476 0.28
Debt/Equity
0.74 0.79 0.85 1.13 1.33 0.95 0.4712 0.5304 2.03 2.03 3.49
Debt/Net Income
3.55 3.69 2.54 3.87 4.5 1.23 4.02 1.67 1.67 1.67 8.65
Бета
0.54 0.47 -0.2118 0.8904 0.8904 -0.15
Индекс Альтмана
2.81 2.96 2.92 3.42 2.85 4.19 6.95 3.64 4.28 4.28 3.89


Dividends

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
Див.выплата, млрд
6.64 6.5 6.97 6.65 6.99 7.37 29.61 7.26 7.26 29.77
Дивиденд
2.72 2.72 2.94 2.83 3.09 3.2 3.47 3.47 3.78 3.78
Див доход, ао, %
4.25 3.69 3.9 2.99 3.27 2.38 4.01 3.77 3.87 3.87 1.87
Дивиденды / прибыль, %
77.7 95.7 96.7 51.4 93.5 99.9 73.8 104.31 48.86 48.86 130.94


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM CAGR 5
НИОКР, млрд
8.97 9.07 9.4 9.4 8.98 9.54 10 11.37 10
Всего задолженность
29.61 28.26 33.06
Персонал, чел
109000 104323 101703 76057